Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

John A Thompson

TitleAsst Professor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-Neurosurgery
Phone303/724-8581

    Collapse Research 
    Collapse research activities and funding
    R01CA041248     (THOMPSON, JOHN A)Mar 1, 1986 - Jul 31, 2008
    NIH/NCI
    Bioactivation of Dietary Phenols by Hemoproteins
    Role: Principal Investigator

    S10RR004996     (THOMPSON, JOHN A)Sep 30, 1988 - Sep 29, 1989
    NIH/NCRR
    LIQUID CHROMATOGRAPH-MASS SPECTROMETER
    Role: Principal Investigator

    R01HL048491     (THOMPSON, JOHN ANTHONY)Apr 1, 1992 - Jan 31, 1996
    NIH/NHLBI
    PATHOLOGICAL ANGIOGENESIS--REGULATION BY TAT AND HBGF-1
    Role: Principal Investigator

    R01HL045990     (THOMPSON, JOHN ANTHONY)Feb 1, 1993 - Mar 31, 2008
    NIH/NHLBI
    Molecular Mechanisms of Angiogenesis
    Role: Principal Investigator

    R01ES006216     (THOMPSON, JOHN A)May 1, 1994 - Apr 30, 1997
    NIH/NIEHS
    FORMATION AND REACTIVITY OF TOXIC QUINONE METHIDES
    Role: Principal Investigator

    R01DK051629     (THOMPSON, JOHN ANTHONY)Aug 22, 1997 - May 31, 2002
    NIH/NIDDK
    PRECLINICAL MODEL OF CHRONIC RENAL ALLOGRAFT REJECTION
    Role: Principal Investigator

    S10RR012974     (THOMPSON, JOHN A)May 15, 1998 - May 14, 1999
    NIH/NCRR
    ACQUISTION OF AN ELECTROSPRAY TANDEM MASS SPECTROMETER
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Stratford JM, Thompson JA, Finger TE. Immunocytochemical organization and sour taste activation in the rostral nucleus of the solitary tract of mice. J Comp Neurol. 2017 Feb 01; 525(2):271-290. PMID: 27292295.
      View in: PubMed
    2. Dondzillo A, Thompson JA, Klug A. Recurrent Inhibition to the Medial Nucleus of the Trapezoid Body in the Mongolian Gerbil (Meriones Unguiculatus). PLoS One. 2016; 11(8):e0160241. PMID: 27489949.
      View in: PubMed
    3. Stratford JM, Thompson JA. Beta-galactosidase staining in the nucleus of the solitary tract of Fos-Tau-LacZ mice is unaffected by monosodium glutamate taste stimulation. PLoS One. 2014; 9(9):e107238. PMID: 25192442.
      View in: PubMed
    4. Thompson JA, Salcedo E, Restrepo D, Finger TE. Second-order input to the medial amygdala from olfactory sensory neurons expressing the transduction channel TRPM5. J Comp Neurol. 2012 Jun 01; 520(8):1819-30. PMID: 22120520.
      View in: PubMed
    5. Shrestha SP, Thompson JA, Wempe MF, Gu M, Agarwal R, Agarwal C. Glucuronidation and methylation of procyanidin dimers b2 and 3,3?-di-o-galloyl-b2 and corresponding monomers epicatechin and 3-o-galloyl-epicatechin in mouse liver. Pharm Res. 2012 Mar; 29(3):856-65. PMID: 22068277.
      View in: PubMed
    6. Shearn CT, Fritz KS, Thompson JA. Protein damage from electrophiles and oxidants in lungs of mice chronically exposed to the tumor promoter butylated hydroxytoluene. Chem Biol Interact. 2011 Jul 15; 192(3):278-86. PMID: 21536018.
      View in: PubMed
    7. Chou SC, Kaur M, Thompson JA, Agarwal R, Agarwal C. Influence of gallate esterification on the activity of procyanidin B2 in androgen-dependent human prostate carcinoma LNCaP cells. Pharm Res. 2010 Apr; 27(4):619-27. PMID: 20162340.
      View in: PubMed
    8. Shearn CT, Fritz KS, Meier BW, Kirichenko OV, Thompson JA. Carbonyl reductase inactivation may contribute to mouse lung tumor promotion by electrophilic metabolites of butylated hydroxytoluene: protein alkylation in vivo and in vitro. Chem Res Toxicol. 2008 Aug; 21(8):1631-41. PMID: 18597497.
      View in: PubMed
    9. Lewis KD, Thompson JA, Weber JS, Robinson WA, O'Day S, Lutzky J, Legha SS, Floret S, Ruvuna F, Gonzalez R. A phase II open-label trial of apomine (SR-45023A) in patients with refractory melanoma. Invest New Drugs. 2006 Jan; 24(1):89-94. PMID: 16379038.
      View in: PubMed
    Thompson's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _

    Copyright © 2017 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.10.0)